Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.



Brand Name Molecule ATC Category
Packaging Class
Ketesse 25 Dexketoprofen trometamol Antiinflammatory and antirheumatic drugs 20 tablets film-coated 25 mg C
Miolene Ritodrine hydrochloride Sympathomimetics, tocolitics 3 vials 5 ml / 50 mg i.v. A
Ulcex Ritodrine hydrochlorideo

H2-receptor antagonists

20 tablets 150 mg A48
20 tablets 300 mg A48

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.


The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl


Copyright 2020 Istituto Lusofarmaco D'Italia S.p.A.